Nutriband Inc.(NTRB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NTRB Nutriband Inc.

Market Closed 01-23 16:00:00 EST

4.80

+0.28

+6.19%

盘后4.80

+0.000.00%

19:43 EST

High4.85	Low4.42	Vol30.27K
Open4.50	D1 Closing4.52	Amplitude9.51%
Mkt Cap58.44M	Tradable Cap18.70M	Total Shares12.17M
T/O138.77K	T/O Rate0.78%	Tradable Shares3.90M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NTRB","market":"US","secType":"STK","nameCN":"Nutriband Inc.","latestPrice":4.8,"timestamp":1769202000000,"preClose":4.52,"halted":0,"volume":30269,"hourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.8,"latestTime":"19:43 EST","volume":333,"amount":1598.4,"timestamp":1769215428562,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.06194690265486732,"floatShares":3895299,"shares":12174883,"eps":-3.040529,"marketStatus":"Market Closed","change":0.28,"latestTime":"01-23 16:00:00 EST","open":4.5,"high":4.85,"low":4.4201,"amount":138766.1328583,"amplitude":0.095111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.040529,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1769418000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.52,"preHourTrading":{"tag":"盘前","latestPrice":4.52,"preClose":4.52,"latestTime":"09:29 EST","volume":4,"amount":18.08,"timestamp":1769178599013,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.8,"latestTime":"19:43 EST","volume":333,"amount":1598.4,"timestamp":1769215428562,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.738478663415424},"requestUrl":"/m/hq/s/NTRB/tweets","defaultTab":"tweets","newsList":[{"id":"2595077602","title":"Nutriband Inc. joins Russell Microcap and Russell 3000E Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2595077602","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595077602?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:00","pubTimestamp":1767182411,"startTime":"0","endTime":"0","summary":"Nutriband Inc. will be added to four indexes—the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes—as part of the 2025 Russell indexes reconstitution. No specific reason for the addition is provided in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via GlobeNewswire  on December 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL3mWf0f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","NDAQ","BK4112","BK4585","SG9999014039.USD","LU2210150020.SGD","BK4007","NTRB","LU0314104364.USD"],"gpt_icon":0},{"id":"2595377939","title":"Nutriband CEO Publishes Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2595377939","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595377939?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:00","pubTimestamp":1767182400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Dec.  31, 2025  (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on ach","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/31/3211738/0/en/Nutriband-CEO-Publishes-Letter-to-Shareholders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMC","LU0170899867.USD","NTRB","IE00B1BXHZ80.USD","LU0971096721.USD","BK4604","LU0149725797.USD","BK4139","LU0267386448.USD","IE00BZ1G4Q59.USD","BK4007","NTRBW","BK4006","CDMO","IE00BHPRN162.USD","LU1363072403.SGD","IE00BKVL7J92.USD","LU2237443465.HKD","IND","BK4585","BK4588","BK4555","LU2746668461.USD","LU2237443382.USD","BK4099","LU2237443549.SGD","TM","IE00BFXG1179.USD","03160","LU0882574139.USD","LU2237443895.HKD","LU2746668974.SGD","LU2237443978.SGD","LU2237443622.USD"],"gpt_icon":0},{"id":"2595142718","title":"Nutriband (NASDAQ:NTRB) shareholders are up 27% this past week, but still in the red over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2595142718","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595142718?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:20","pubTimestamp":1767090027,"startTime":"0","endTime":"0","summary":"Nutriband Inc. ( NASDAQ:NTRB ) shareholders should be happy to see the share price up 27% in the last week. But that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntrb/nutriband/news/nutriband-nasdaqntrb-shareholders-are-up-27-this-past-week-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntrb/nutriband/news/nutriband-nasdaqntrb-shareholders-are-up-27-this-past-week-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QLD",".IXIC","BK4007","USJW.SI","NTRB","TSYW.SI","PSQ","SQQQ","TQQQ","USAW.SI","NVIW.SI","QID","MNQmain","NQmain"],"gpt_icon":1},{"id":"2595773345","title":"Nutriband Sells 90% Stake in Pocono Pharmaceutical to EarthVision Bio for $5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2595773345","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595773345?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:00","pubTimestamp":1767016822,"startTime":"0","endTime":"0","summary":"Nutriband Inc. has signed an agreement to sell a 90% interest in its subsidiary, Pocono Pharmaceutical, to EarthVision Bio for $5 million USD. As part of the deal, Nutriband Inc. shareholders will retain a 10% shareholding in EarthVision Bio following the acquisition. The transaction is expected to close by December 31, 2025. Proceeds from the sale will be used by Nutriband Inc. to support the continued development of AVERSA Fentanyl, an abuse-deterrent opioid patch. EarthVision Bio is focused on developing and commercializing sustainable product alternatives to plastic, molded fiber, wood, and paper, based on innovations by Dr. Gordon Moore and Dr. Hans Franke.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL2vSDB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","IE00B64PRP62.GBP","NTRB","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","BK4007","BK4585","BK4112"],"gpt_icon":0},{"id":"2595733978","title":"Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to Earthvision Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2595733978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595733978?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:00","pubTimestamp":1767016800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA5WWNXW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRB","BK4007"],"gpt_icon":0},{"id":"2595733439","title":"Nutriband Inc - Proceeds to Fund Development of Aversa Fentanyl Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2595733439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595733439?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:00","pubTimestamp":1767016800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA5WWNXW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRB","BK4007","NTRBW"],"gpt_icon":0},{"id":"2595339277","title":"Nutriband Inc - Shareholders to Retain 10% Stake in Earth Vision Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2595339277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595339277?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:00","pubTimestamp":1767016800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA5WWNXW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRBW","NTRB","BK4007"],"gpt_icon":0},{"id":"2592195094","title":"Nutriband Inc. Announces Date for Upcoming Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2592195094","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592195094?lang=en_us&edition=fundamental","pubTime":"2025-12-20 00:02","pubTimestamp":1766160166,"startTime":"0","endTime":"0","summary":"Nutriband Inc. will hold its Annual Meeting of Stockholders in Orlando, Florida, on January 24, 2026. Shareholders will vote on the election of seven directors to the company’s Board of Directors, each to serve until the next annual meeting or until a successor is elected and qualified, or until earlier resignation or removal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL48BJTS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTRB"],"gpt_icon":0},{"id":"2592906124","title":"BRIEF-Nutriband Signs Letter Of Intent With Qvanta Group Of Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906124","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906124?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:09","pubTimestamp":1766063355,"startTime":"0","endTime":"0","summary":"BRIEF-Nutriband Signs Letter Of Intent With Qvanta Group Of Companies Dec 18 (Reuters) - Nutriband Inc NTRB.O:NUTRIBAND INC. SIGNS LETTER OF INTENT WITH QVANTA GROUP OF COMPANIES TO EXPLORE ADVANCED T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRB","BK4007"],"gpt_icon":0},{"id":"2592065929","title":"Nutriband Signs LOI to Explore Quantum-AI Collaboration with Qvanta Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2592065929","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592065929?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:02","pubTimestamp":1766062969,"startTime":"0","endTime":"0","summary":"Nutriband Inc., a developer of transdermal pharmaceutical products with abuse-deterrent technologies, has signed a non-binding Letter of Intent with the Qvanta Group of Companies to explore potential collaboration in advanced technology solutions. The parties aim to evaluate secure AI and analytics platforms for regulated pharmaceutical data, cybersecurity frameworks for abuse-deterrent technologies, and advanced modeling capabilities utilizing quantum-ready infrastructure. The agreement is exploratory and does not constitute a formal partnership or binding commercial relationship at this stage, with any future collaboration subject to further technical and regulatory review and definitive agreements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL13RCPh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","NTRB","SG9999014021.USD","LU2095319765.USD","SG9999014013.SGD","LU2210149790.SGD","BK4112","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","BK4588","LU0314104364.USD","SG9999014005.SGD","IE00BGHQF748.EUR","SG9999014039.USD","BK4007"],"gpt_icon":0},{"id":"2592390635","title":"Nutriband Inc. Signs Letter of Intent With Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration","url":"https://stock-news.laohu8.com/highlight/detail?id=2592390635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592390635?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:00","pubTimestamp":1766062845,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NTRB"],"gpt_icon":0},{"id":"2592908470","title":"Nutriband Partners with Kindeva to Develop Abuse-Deterrent Fentanyl Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2592908470","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592908470?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:00","pubTimestamp":1766059252,"startTime":"0","endTime":"0","summary":"Nutriband Inc. has partnered with Kindeva to develop AVERSA Fentanyl, a new abuse-deterrent transdermal fentanyl patch. This collaboration combines Nutriband’s AVERSA abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. The joint effort aims to improve the safety profile of fentanyl patches by incorporating agents that deter misuse, while ensuring continued access for patients in need of effective pain management.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via GlobeNewswire  on December 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL91LMck:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","NTRB","SG9999014005.SGD","SG9999014013.SGD","SG9999014021.USD","LU2210149790.SGD","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","BK4112","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4007","LU0314104364.USD"],"gpt_icon":0},{"id":"2592903585","title":"Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction","url":"https://stock-news.laohu8.com/highlight/detail?id=2592903585","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592903585?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:00","pubTimestamp":1766059200,"startTime":"0","endTime":"0","summary":"Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatmen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/18/3207557/0/en/Nutriband-Differentiates-Prescription-Fentanyl-from-Illicit-Fentanyl-in-Response-to-United-States-Executive-Order-Designating-Fentanyl-as-a-Weapon-of-Mass-Destruction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRB","BK4211","NTRBW","UBCP","BK4007"],"gpt_icon":0},{"id":"2585461304","title":"Nutriband Inc. to Present at Noble Capital Markets Emerging Growth Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2585461304","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585461304?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:01","pubTimestamp":1763985662,"startTime":"0","endTime":"0","summary":"Nutriband Inc.  will present at NobleCon21, the Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference, on Wednesday, December 3rd, 2025, at 9:30 AM EST. The event will take place at Florida Atlantic University's Executive Education Complex in Boca Raton, Florida. Investors and guests can attend at a discounted rate using the code NTRBNOBLECON, and a webcast of the presentation will be available the following day on the Noble Conference website and Channelchek.com.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via Newsfile  on November 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL4wCrvx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTRB"],"gpt_icon":0},{"id":"2578953818","title":"Nutriband Inc - Meets With FDA for Aversa Fentanyl Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2578953818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578953818?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:19","pubTimestamp":1761650396,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W913C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRBW","BK4007","NTRB"],"gpt_icon":0},{"id":"2578953622","title":"Nutriband announces meeting completed with U.S. FDA for AVERSA FENTANYL","url":"https://stock-news.laohu8.com/highlight/detail?id=2578953622","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578953622?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:15","pubTimestamp":1761650136,"startTime":"0","endTime":"0","summary":"Nutriband (NTRB) announced that it has received final meeting minutes from its recent virtual face-to-face meeting held on September 18, 2025 with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nutriband-announces-meeting-completed-with-u-s-fda-for-aversa-fentanyl-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nutriband-announces-meeting-completed-with-u-s-fda-for-aversa-fentanyl-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTRB","BK4007"],"gpt_icon":0},{"id":"2578959854","title":"Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2578959854","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578959854?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:00","pubTimestamp":1761649200,"startTime":"0","endTime":"0","summary":"Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175223/0/en/Nutriband-Announces-Successful-Meeting-Completed-With-United-States-FDA-For-Its-Abuse-Deterrent-Fentanyl-Patch.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4512","LU1548497426.USD","BK4141","LU2746668974.SGD","IE00BKVL7J92.USD","LU0170899867.USD","IE00BFMHRM44.USD","LU1861215975.USD","IE00BHPRN162.USD","LU1854104046.USD","UBCP","LU0882574139.USD","LU1861220033.SGD","BK4007","LU0267386448.USD","LU2357305700.SGD","IE00BZ199S13.USD","CMC","LU1363072403.SGD","LU2237443382.USD","BK4006","LU1861214812.USD","LU1861219969.SGD","IE00BD6J9T35.USD","BK4605","BK4585","NTRBW","LU2746668461.USD","NTRB","LU2237443622.USD","IE00B1BXHZ80.USD","ON","LU2237443978.SGD","IE00BFXG1179.USD","LU0149725797.USD","LU1720051017.SGD","HAP","LU0724618433.USD","LU2237443465.HKD","BK4588","LU2237443895.HKD","LU1978683503.SGD","LU2298322129.HKD","LU2360107325.USD","IE00BZ1G4Q59.USD","LU0124384867.USD","LU1720051108.HKD","LU2237443549.SGD","LU1854103824.USD","LU0348723411.USD"],"gpt_icon":0},{"id":"2578610552","title":"Press Release: Nutriband Co-Founder Gareth Sheridan Returns as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2578610552","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578610552?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:00","pubTimestamp":1761562800,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Oct. 27, 2025  -- Nutriband Inc.  has announced that Company founder, Gareth Sheridan has returned as Company CEO.During the period of August 10 until October 27 , Co-Founder and Chairman, Serguei Melnik had taken over the responsibilities of CEO. Mr Sheridan has returned to the position of CEO effective immediately and will guide the company through the final 2025 framework towards the target NDA filing in 2026 for AVERSA Fentanyl.AVERSA FENTANYL has the potential to be the world's first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. AVERSA FENTANYL has the potential to reach peak annual US sales of $80 million to $200 million. While initially concentrating on the US market, the unmet medical need for adequate pain management is a global problem, and our goal is to make AVERSA FENTANYL available in all major medical markets in the world.Certain statements contained in this p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","TM","NTRBW","BK4604","03160","BK4588","BK4007","BK4585","BK4099","NTRB"],"gpt_icon":0},{"id":"2577881365","title":"Nutriband (NTRB) Receives a Buy from Noble Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2577881365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577881365?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:55","pubTimestamp":1761227718,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Nutriband today and set a price target of $15.00. The company’s shares opened tod...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/nutriband-ntrb-receives-a-buy-from-noble-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/nutriband-ntrb-receives-a-buy-from-noble-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTRB","BK4007","NBL"],"gpt_icon":0},{"id":"2574120115","title":"Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2574120115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574120115?lang=en_us&edition=fundamental","pubTime":"2025-10-10 19:00","pubTimestamp":1760094026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR1I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NTRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nutriband.com","stockEarnings":[{"period":"1week","weight":0.1009},{"period":"1month","weight":0.0127},{"period":"3month","weight":-0.3287},{"period":"6month","weight":-0.4373},{"period":"1year","weight":-0.5152},{"period":"ytd","weight":0.0573}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.0177},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.0107}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.051584},{"month":2,"riseRate":0.428571,"avgChangeRate":0.079955},{"month":3,"riseRate":0.571429,"avgChangeRate":0.125817},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.102426},{"month":5,"riseRate":0.375,"avgChangeRate":0.114405},{"month":6,"riseRate":0.5,"avgChangeRate":0.054322},{"month":7,"riseRate":0.375,"avgChangeRate":-0.040174},{"month":8,"riseRate":0.375,"avgChangeRate":0.254116},{"month":9,"riseRate":0.375,"avgChangeRate":-0.066827},{"month":10,"riseRate":0.5,"avgChangeRate":0.214567},{"month":11,"riseRate":0.375,"avgChangeRate":-0.106737},{"month":12,"riseRate":0.375,"avgChangeRate":0.070788}],"exchange":"NASDAQ","name":"Nutriband Inc.","nameEN":"Nutriband Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nutriband Inc.(NTRB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nutriband Inc.(NTRB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nutriband Inc.,NTRB,Nutriband Inc.股票,Nutriband Inc.股票老虎,Nutriband Inc.股票老虎国际,Nutriband Inc.行情,Nutriband Inc.股票行情,Nutriband Inc.股价,Nutriband Inc.股市,Nutriband Inc.股票价格,Nutriband Inc.股票交易,Nutriband Inc.股票购买,Nutriband Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nutriband Inc.(NTRB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nutriband Inc.(NTRB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction